» Articles » PMID: 28395660

Incentivised Chronic Disease Management and the Inverse Equity Hypothesis: Findings from a Longitudinal Analysis of Scottish Primary Care Practice-level Data

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2017 Apr 12
PMID 28395660
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The inverse equity hypothesis asserts that new health policies initially widen inequality, then attenuate inequalities over time. Since 2004, the UK's pay-for-performance scheme for chronic disease management (CDM) in primary care general practices (the Quality and Outcomes Framework) has permitted practices to except (exclude) patients from attending annual CDM reviews, without financial penalty. Informed dissent (ID) is one component of exception rates, applied to patients who have not attended due to refusal or non-response to invitations. 'Population achievement' describes the proportion receiving care, in relation to those eligible to receive it, including excepted patients. Examination of exception reporting (including ID) and population achievement enables the equity impact of the UK pay-for-performance contract to be assessed. We conducted a longitudinal analysis of practice-level rates and of predictors of ID, overall exceptions and population achievement for CDM to examine whether the inverse equity hypothesis holds true.

Methods: We carried out a retrospective, longitudinal study using routine primary care data, analysed by multilevel logistic regression. Data were extracted from 793 practices (83% of Scottish general practices) serving 4.4 million patients across Scotland from 2010/2011 to 2012/2013, for 29 CDM indicators covering 11 incentivised diseases. This provided 68,991 observations, representing a total of 15 million opportunities for exception reporting.

Results: Across all observations, the median overall exception reporting rate was 7.0% (7.04% in 2010-2011; 7.02% in 2011-2012 and 6.92% in 2012-2013). The median non-attendance rate due to ID was 0.9% (0.76% in 2010-2011; 0.88% in 2011-2012 and 0.96% in 2012-2013). Median population achievement was 83.5% (83.51% in 2010-2011; 83.41% in 2011-2012 and 83.63% in 2012-2013). The odds of ID reporting in 2012/2013 were 16.0% greater than in 2010/2011 (p < 0.001). Practices in Scotland's most deprived communities were twice as likely to report non-attendance due to ID (odds ratio 2.10, 95% confidence interval 1.83-2.40, p < 0.001) compared with those in the least deprived; rural practices reported lower levels of non-attendance due to ID. These predictors were also independently associated with overall exceptions. Rates of population achievement did not change over time, with higher levels (higher remuneration) associated with increased rates of overall and ID exception and more affluent practices.

Conclusions: Non-attendance for CDM due to ID has risen over time, and higher rates are seen in patients from practices located in disadvantaged areas. This suggests that CDM incentivisation does not conform to the inverse equity hypothesis, because inequalities are widening over time with lower uptake of anticipatory care health checks and CDM reviews noted among those most in need. Incentivised CDM needs to include incentives for engaging with the 'hard to reach' if inequalities in healthcare delivery are to be tackled.

Citing Articles

Identification and management of frailty in English primary care: a qualitative study of national policy.

Alharbi K, van Marwijk H, Reeves D, Blakeman T BJGP Open. 2020; 4(1).

PMID: 32184213 PMC: 7330193. DOI: 10.3399/bjgpopen20X101019.


Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.

Whyte M, Hinton W, McGovern A, van Vlymen J, Ferreira F, Calderara S PLoS Med. 2019; 16(10):e1002942.

PMID: 31589609 PMC: 6779242. DOI: 10.1371/journal.pmed.1002942.


A non-randomised controlled pilot study of clinical pharmacist collaborative intervention for community dwelling patients with COPD.

Hunt V, Anderson D, Lowrie R, Montgomery Sardar C, Ballantyne S, Bryson G NPJ Prim Care Respir Med. 2018; 28(1):38.

PMID: 30305634 PMC: 6180130. DOI: 10.1038/s41533-018-0105-7.

References
1.
Blustein J, Weissman J, Ryan A, Doran T, Hasnain-Wynia R . Analysis raises questions on whether pay-for-performance in Medicaid can efficiently reduce racial and ethnic disparities. Health Aff (Millwood). 2011; 30(6):1165-75. DOI: 10.1377/hlthaff.2010.1022. View

2.
McDonald R, Roland M . Pay for performance in primary care in England and California: comparison of unintended consequences. Ann Fam Med. 2009; 7(2):121-7. PMC: 2653973. DOI: 10.1370/afm.946. View

3.
Roland M . Linking physicians' pay to the quality of care--a major experiment in the United kingdom. N Engl J Med. 2004; 351(14):1448-54. DOI: 10.1056/NEJMhpr041294. View

4.
Doran T, Kontopantelis E, Fullwood C, Lester H, Valderas J, Campbell S . Exempting dissenting patients from pay for performance schemes: retrospective analysis of exception reporting in the UK Quality and Outcomes Framework. BMJ. 2012; 344:e2405. PMC: 3328418. DOI: 10.1136/bmj.e2405. View

5.
Ashworth M, Medina J, Morgan M . Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework. BMJ. 2008; 337:a2030. PMC: 2590907. DOI: 10.1136/bmj.a2030. View